<DOC>
	<DOCNO>NCT00003308</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . PURPOSE : Phase II trial study effectiveness radiation therapy treat patient newly diagnose brain metastasis kidney cancer , melanoma , sarcoma .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer , Melanoma , Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate whether delivery stereotactic radiosurgery without conventional whole brain radiotherapy feasible patient 1-3 newly diagnose brain metastasis renal cell carcinoma , melanoma , sarcoma . - Determine 3- , 6- , 12-month radiographic neurologic intracranial pattern progression ( i.e. , original lesion vs new lesion ) patient treat regimen . OUTLINE : This multicenter study . Patients stratify accord maximum tumor diameter ( 2 cm v great 2 cm 3 cm v great 3 cm 4 cm ) . Patients undergo stereotactic radiosurgery assign dose accord tumor diameter . Patients undergo MRI CT scan 3 , 6 , 12 month treatment disease progression . All therapy allow stereotactic radiosurgery except external beam whole brain radiotherapy resection brain metastasis , unless document progression unrelenting mass effect necessitate craniotomy . Patients follow every 3 month 2 year . PROJECTED ACCRUAL : A total 36 patient accrue study within 7.2 month .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm renal cell carcinoma , melanoma , sarcoma 13 newly diagnose intraparenchymal brain metastasis base contrastenhanced MRI ( CT scan acceptable patient medical contraindication MRI ) No lesion great 4.0 cm diameter , multiple lesion present , one great 3.0 cm diameter No limitation extent extracranial metastatic disease No metastases brain stem , midbrain , pons , medulla No leptomeningeal metastasis document MRI CSF evaluation No metastasis within 10 mm optic nerve chiasm No history multiple liver metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 3 month Hematopoietic : Absolute neutrophil count great 1,000/mm^3 Platelet count great 50,000/mm^3 Hemoglobin great 8 g/dL Hepatic : Not specify Renal : Not specify Other : No major medical illness No psychoses Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy allow Systemic chemotherapy may continue discretion investigator completion radiosurgery Endocrine therapy : Not specify Radiotherapy : No prior cranial radiotherapy Prior concurrent radiotherapy noncranial site allow Surgery : No prior surgical resection brain metastasis Prior stereotactic biopsy diagnostic purpose allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>chondrosarcoma</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>